-5%
Tirzep is prescribed to improve blood sugar control in adults with type 2 diabetes in combination with a healthy diet and regular exercise.
- It has not been tested in people with a history of pancreatitis.
- It is not meant for patients with type 1 diabetes.
Not approved for use in individuals under 18 years old
Tirzepatide is a dual receptor agonist that activates both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptors. It’s a modified 39-amino-acid peptide with a fatty acid chain (C20) that allows for albumin binding, extending its duration of action.
Mechanism of action:
- Stimulates insulin secretion (both first and second phases)
- Lowers glucagon levels, both in a glucose-dependent way